Oncology & Cancer

TTFields tied to improved survival in glioblastoma patients

(HealthDay)—For patients with glioblastoma, the addition of tumor-treating fields (TTFields) to standard treatment with temozolomide is associated with improved survival without negative effects on health-related quality ...

Oncology & Cancer

Glioblastoma survival mechanism reveals new therapeutic target

A Northwestern Medicine study, published in the journal Cancer Cell, has provided new insights into a mechanism of tumor survival in glioblastoma and demonstrated that inhibiting the process could enhance the effects of radiation ...

Oncology & Cancer

Vulnerability identified for subtypes of glioblastoma

Glioblastoma, the most common and aggressive form of brain cancer, typically fails to respond to treatment or rapidly becomes drug resistant. In a paper published online in the journal Cancer Cell on November 30, University ...

Oncology & Cancer

Cancer drug starts clinical trials in human brain-cancer patients

A drug that spurs cancer cells to self-destruct has been cleared for use in a clinical trial of patients with anaplastic astrocytoma, a rare malignant brain tumor, and glioblastoma multiforme, an aggressive late-stage cancer ...

page 25 from 40